Icagen, Inc. and Pfizer Inc. Form Collaboration With Birkbeck, University of London to Elucidate Channel Structure

RESEARCH TRIANGLE PARK, N.C., March 20, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that, together with Pfizer, it has entered into a collaboration with the laboratory of Professor B. A. Wallace at Birkbeck, University of London, to study the structural biology of sodium channels. This three party relationship has been established to support a previously established collaboration between Icagen and Pfizer for the discovery of compounds which modulate specific sodium ion channels as potential new treatments for pain and related disorders.